From: International comparison of the factors influencing reimbursement of targeted anti-cancer drugs
UK | Canada | Australia | Sweden | France | Japan | Korea | Taiwan | Germany | |
---|---|---|---|---|---|---|---|---|---|
GDP per capita in US$ (2009) | 34397 | 37773 | 39833 | 37255 | 33785 | 32061 | 26881 | 32214* | 35643 |
Total expenditure on health (TEH), % of GDP (2009) | 9.8 | 11.4 | 9.1 | 9.9 | 11.7 | 9.5 | 6.9 | 6.4* | 11.7 |
Public expenditure on health, % of TEH (2009) | 83.4 | 70.9 | 68.5 | 81.5 | 76.9 | 80.5 | 58.2 | 26.6* | 76.9 |
Out-of-pocket expenditure (households) on health, % of TEH (2009) | 9.1 | 14.2 | 18.6 | 16.4 | 7.4 | 16 | 32.4 | 38.1* | 13 |
Pharmaceutical expenditure and other medical non-durables, % of TEH (2009) | 11.8* | 17 | 14.7 | 12.7 | 16.1 | 20.8 | 22.5 | 25* | 14.9 |
Life expectancy of both sexes at birth in years (2009) | 80.4 | 80.8* | 81.6 | 81.4 | 81.1 | 83 | 80.4 | 79* | 80.3 |